PubRank

Colin Collins

Author PubWeight™ 63.54‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 End-sequence profiling: sequence-based analysis of aberrant genomes. Proc Natl Acad Sci U S A 2003 7.70
2 Chromosome aberrations in solid tumors. Nat Genet 2003 7.01
3 TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion. Am J Surg Pathol 2007 6.09
4 Reconstructing tumor genome architectures. Bioinformatics 2003 2.61
5 Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panel. Mol Cancer Ther 2006 2.55
6 Evaluation of paired-end sequencing strategies for detection of genome rearrangements in cancer. PLoS Comput Biol 2008 2.40
7 High-resolution array comparative genomic hybridization of chromosome arm 8q: evaluation of genetic progression markers for prostate cancer. Genes Chromosomes Cancer 2005 2.25
8 Decoding the fine-scale structure of a breast cancer genome and transcriptome. Genome Res 2006 2.09
9 Overexpression, amplification, and androgen regulation of TPD52 in prostate cancer. Cancer Res 2004 1.82
10 Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors. Hum Mol Genet 2004 1.80
11 Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer. Nat Genet 2002 1.70
12 High-resolution analysis of paraffin-embedded and formalin-fixed prostate tumors using comparative genomic hybridization to genomic microarrays. Am J Pathol 2003 1.57
13 A group of genome-based biomarkers that add to a Kattan nomogram for predicting progression in men with high-risk prostate cancer. Clin Cancer Res 2009 1.56
14 TMPRSS2-ERG status is not prognostic following prostate cancer radiotherapy: implications for fusion status and DSB repair. Clin Cancer Res 2013 1.45
15 Genome amplification of chromosome 20 in breast cancer. Breast Cancer Res Treat 2003 1.29
16 ZNF217 suppresses cell death associated with chemotherapy and telomere dysfunction. Hum Mol Genet 2005 1.25
17 Integration of high-resolution array comparative genomic hybridization analysis of chromosome 16q with expression array data refines common regions of loss at 16q23-qter and identifies underlying candidate tumor suppressor genes in prostate cancer. Oncogene 2004 1.20
18 Optimally discriminative subnetwork markers predict response to chemotherapy. Bioinformatics 2011 1.17
19 Isolation and genomic analysis of circulating tumor cells from castration resistant metastatic prostate cancer. BMC Cancer 2012 1.13
20 nFuse: discovery of complex genomic rearrangements in cancer using high-throughput sequencing. Genome Res 2012 1.12
21 Identification of ovarian cancer metastatic miRNAs. PLoS One 2013 1.09
22 Comrad: detection of expressed rearrangements by integrated analysis of RNA-Seq and low coverage genome sequence data. Bioinformatics 2011 1.08
23 High resolution oligonucleotide CGH using DNA from archived prostate tissue. Prostate 2007 1.05
24 Evolution of 8p loss in transformed human prostate epithelial cells. Cancer Genet Cytogenet 2004 1.03
25 REST mediates androgen receptor actions on gene repression and predicts early recurrence of prostate cancer. Nucleic Acids Res 2013 1.02
26 Evaluation of genetic patterns in different tumor areas of intermediate-grade prostatic adenocarcinomas by high-resolution genomic array analysis. Genes Chromosomes Cancer 2004 1.02
27 Genomic profiling of hormone-naïve lymph node metastases in patients with prostate cancer. Neoplasia 2006 0.97
28 Detection of recurrent rearrangement breakpoints from copy number data. BMC Bioinformatics 2011 0.94
29 Characterization of the novel amplified in breast cancer-1 (NABC1) gene product. Exp Cell Res 2003 0.92
30 Decreased stromal expression and increased epithelial expression of WFDC1/ps20 in prostate cancer is associated with reduced recurrence-free survival. Prostate 2004 0.89
31 Construction and application of a full-coverage, high-resolution, human chromosome 8q genomic microarray for comparative genomic hybridization. Cytometry A 2005 0.88
32 ZNF217 confers resistance to the pro-apoptotic signals of paclitaxel and aberrant expression of Aurora-A in breast cancer cells. Mol Cancer 2010 0.85
33 Computational BAC clone contig assembly for comprehensive genome analysis. Genes Chromosomes Cancer 2004 0.85
34 ORMAN: optimal resolution of ambiguous RNA-Seq multimappings in the presence of novel isoforms. Bioinformatics 2013 0.84
35 Molecular analysis of WFDC1/ps20 gene in prostate cancer. Prostate 2004 0.82
36 Evaluation of whole genome amplification protocols for array and oligonucleotide CGH. Diagn Mol Pathol 2007 0.78
37 Predicting antigenic peptides suitable for the selection of phage antibodies. Hum Antibodies 2003 0.75